MIT chemical engineers have designed an implantable device that can deliver many drugs at once, allowing researchers to determine which drugs are the most effective against a patient’s tumor.
Credit: Eric Smith (edited by Jose-Luis Olivares/MIT)
More than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an inexact science at best.
A new device developed at MIT may change that. The implantable device, about the size of the grain of rice, can carry small doses of up to 30 different drugs. After implanting it in a tumor and letting the drugs diffuse into the tissue, researchers can measure how effectively each one kills the patient’s cancer cells. Such a device could eliminate much of the guesswork now involved in choosing cancer treatments, says Oliver Jonas, a postdoc at MIT’s Koch Institute for Integrative Cancer Research and lead author of a paper describing the device in the April 22 issue of Science Translational Medicine. “You can use it to test a patient for a range of available drugs, and pick the one that works best,” Jonas says. The paper’s senior authors are Robert Langer, the David H. Koch Professor at MIT and a member of the Koch Institute, the Institute for Medical Engineering and Science, and the Department of Chemical Engineering; and Michael Cima, the David H. Koch Professor of Engineering at MIT and a member of the Koch Institute and the Department of Materials Science and Engineering.
Implant to deliver multiple cancer drug
Related Articles
-
Maximizing Roller Compaction Benefits with Proper Excipient Selection
Pharma Live, , Formulation Discussion, 0
The pharmaceutical industry has adopted roller compaction due to its significant advantage in production process efficiency and its applicability...
-
Patient-centered drug discovery as the means to improved R&D productivity
Pharma Live, , Formulation Discussion, 0
1-s2-0-s1359644615001464-mainDownload
-
A novel dissolution method for evaluation of polysaccharide based colon specific delivery systems: A suitable alternative to animal sacrifice
Pharma Live, , Formulation Discussion, 0
1-s2-0-s0928098715001128-mainDownload
-
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective☆
Pharma Live, , Formulation Discussion, 0
1-s2-0-s0169409x07003195-mainDownload
-
Assessing and Improving the Palatability of Pharmaceuticals – Courtesy (PharmTech)
Pharma Live, , Formulation Discussion, 0
Taste may be subjective, but it is crucial to patient compliance, particularly for pediatric treatments. This article reviews methods...
-
Danish discovery accelerates targeted cancer treatment
Pharma Live, , Formulation Discussion, 0
Danish researchers at the University of Copenhagen have discovered how to map more than one protein at a time,...
-
DNA Sequencing – A Review
Pharma Live, , Formulation Discussion, 0
How DNA sequencing is transforming the hunt for new drugs
-
The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation
Pharma Live, , Formulation Discussion, 0
1-s2-0-s0378517311006557-mainDownload